Tetsuya Kanai

1.3k total citations
15 papers, 247 citations indexed

About

Tetsuya Kanai is a scholar working on Neurology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Tetsuya Kanai has authored 15 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 11 papers in Infectious Diseases and 2 papers in Molecular Biology. Recurrent topics in Tetsuya Kanai's work include Myasthenia Gravis and Thymoma (15 papers), Antifungal resistance and susceptibility (11 papers) and Peripheral Neuropathies and Disorders (8 papers). Tetsuya Kanai is often cited by papers focused on Myasthenia Gravis and Thymoma (15 papers), Antifungal resistance and susceptibility (11 papers) and Peripheral Neuropathies and Disorders (8 papers). Tetsuya Kanai collaborates with scholars based in Japan. Tetsuya Kanai's co-authors include Naoki Kawaguchi, Akiyuki Uzawa, Satoshi Kuwabara, Keiichi Himuro, Fumiko Oda, Yukiko Ozawa, Manato Yasuda, Kimiaki Utsugisawa, Tomihiro Imai and Ichiro Yoshino and has published in prestigious journals such as Scientific Reports, Journal of Neurology Neurosurgery & Psychiatry and Neuroreport.

In The Last Decade

Tetsuya Kanai

13 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tetsuya Kanai Japan	10	222	85	21	17	16	15	247
Manato Yasuda Japan	10	184 0.8×	63 0.7×	15 0.7×	7 0.4×	22 1.4×	34	230
Xiao Huan China	10	203 0.9×	75 0.9×	10 0.5×	7 0.4×	15 0.9×	32	235
Anna Green United Kingdom	7	92 0.4×	61 0.7×	30 1.4×	31 1.8×	18 1.1×	15	197
Chiara Di Schino Italy	7	348 1.6×	70 0.8×	63 3.0×	51 3.0×	11 0.7×	10	384
María Jesús García-Villanueva Spain	6	30 0.1×	33 0.4×	12 0.6×	3 0.2×	18 1.1×	12	86
Paula Schum United States	2	15 0.1×	18 0.2×	15 0.7×	11 0.6×	12 0.8×	2	124
N. V. Lomakin Russia	6	32 0.1×	42 0.5×	13 0.6×	2 0.1×	19 1.2×	29	126
Emmanuelle Proust-Lemoine France	7	31 0.1×	21 0.2×	15 0.7×	190 11.2×	25 1.6×	18	263
Artemis Papadaki United Kingdom	4	65 0.3×	69 0.8×	15 0.7×		50 3.1×	8	175
Jean‐Baptiste Julla France	8	22 0.1×	33 0.4×	40 1.9×	60 3.5×	36 2.3×	22	176

Countries citing papers authored by Tetsuya Kanai

Since Specialization

Citations

This map shows the geographic impact of Tetsuya Kanai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Kanai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Kanai more than expected).

Fields of papers citing papers by Tetsuya Kanai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Kanai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Kanai. The network helps show where Tetsuya Kanai may publish in the future.

Co-authorship network of co-authors of Tetsuya Kanai

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuya Kanai. A scholar is included among the top collaborators of Tetsuya Kanai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuya Kanai. Tetsuya Kanai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Himuro, Keiichi, et al.. (2024). Quantitative Assessment of Dysphagia in Myasthenia Gravis. Internal Medicine. 64(10). 1503–1509.

Ozawa, Yukiko, Akiyuki Uzawa, Manato Yasuda, et al.. (2021). Long-term outcomes and prognostic factors in generalized myasthenia gravis. Journal of Neurology. 268(10). 3781–3788. 9 indexed citations

Yamamoto, Yohei, Naoko Matsui, Akiyuki Uzawa, et al.. (2021). Intrathymic Plasmablasts Are Affected in Patients With Myasthenia Gravis With Active Disease. Neurology Neuroimmunology & Neuroinflammation. 8(6). 9 indexed citations

Uzawa, Akiyuki, Yukiko Ozawa, Manato Yasuda, et al.. (2021). High mobility group box 1 is involved in the pathogenesis of passive transfer myasthenia gravis model. Neuroreport. 32(9). 803–807. 2 indexed citations

Uzawa, Akiyuki, Yukiko Ozawa, Manato Yasuda, et al.. (2019). Increased serum acetylcholine receptor α1 subunit protein in anti-acetylcholine receptor antibody-positive myasthenia gravis. Journal of Neuroimmunology. 339. 577125–577125. 3 indexed citations

Ozawa, Yukiko, Akiyuki Uzawa, Tetsuya Kanai, et al.. (2019). Efficacy of high-dose intravenous methylprednisolone therapy for ocular myasthenia gravis. Journal of the Neurological Sciences. 402. 12–15. 21 indexed citations

Kanai, Tetsuya, Akiyuki Uzawa, Naoki Kawaguchi, et al.. (2018). Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis. Journal of the Neurological Sciences. 396. 8–11. 19 indexed citations

Nagane, Yuriko, Hiroyuki Murai, Tomihiro Imai, et al.. (2017). Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study. BMJ Open. 7(2). e013278–e013278. 52 indexed citations

Uzawa, Akiyuki, Hitoshi Tanaka, Naoki Kawaguchi, et al.. (2016). A Novel Fusion Protein, AChR-Fc, Ameliorates Myasthenia Gravis by Neutralizing Antiacetylcholine Receptor Antibodies and Suppressing Acetylcholine Receptor-Reactive B Cells. Neurotherapeutics. 14(1). 191–198. 5 indexed citations

10.

Kanai, Tetsuya, Akiyuki Uzawa, Naoki Kawaguchi, et al.. (2016). HLA-DRB1*14 and DQB1*05 are associated with Japanese anti-MuSK antibody-positive myasthenia gravis patients. Journal of the Neurological Sciences. 363. 116–118. 21 indexed citations

11.

Uzawa, Akiyuki, Tetsuya Kanai, Naoki Kawaguchi, et al.. (2016). Relationship between damage‐associated molecular patterns and cytokines in myasthenia gravis. Clinical and Experimental Neuroimmunology. 7(4). 357–360. 1 indexed citations

12.

Uzawa, Akiyuki, Tetsuya Kanai, Naoki Kawaguchi, et al.. (2016). Changes in inflammatory cytokine networks in myasthenia gravis. Scientific Reports. 6(1). 46 indexed citations

13.

Uzawa, Akiyuki, Naoki Kawaguchi, Tetsuya Kanai, et al.. (2015). Increased serum peroxiredoxin 5 levels in myasthenia gravis. Journal of Neuroimmunology. 287. 16–18. 14 indexed citations

14.

Uzawa, Akiyuki, Naoki Kawaguchi, Tetsuya Kanai, et al.. (2015). Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis. Journal of Neurology. 262(4). 1019–1023. 22 indexed citations

15.

Uzawa, Akiyuki, Naoki Kawaguchi, Tetsuya Kanai, Keiichi Himuro, & Satoshi Kuwabara. (2014). Serum high mobility group box 1 is upregulated in myasthenia gravis. Journal of Neurology Neurosurgery & Psychiatry. 86(6). 695–697. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact